2010
DOI: 10.1016/j.biocel.2010.06.012
|View full text |Cite
|
Sign up to set email alerts
|

Stem cells in the spleen: Therapeutic potential for Sjogren's syndrome, type I diabetes, and other disorders

Abstract: The view of the spleen as an unnecessary organ has been shattered. The evidence shows the spleen to be a source of naturally-occurring multipotent stem cells with possibly pluripotent potential. The stem cells are sequestered in the spleen of not only of animals but also of normal human adults. The reservoir of cells is set for differentiation and they need not be manipulated in vitro or ex vivo before autologous or heterologous use. Splenic stem cells, of Hox11 lineage, have been found in disease or injury to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
19
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 29 publications
2
19
0
Order By: Relevance
“…The spleen of adult mice contains a pool of multipotent CD45 − /Hox11 + stem cells that reside in the sub-capsular red pulp and are capable of differentiating into diverse lineages4647. Consistent with these reports, we observed a limited number of cells with nuclear Sox2 protein expression in the sub-capsular region of WT mouse spleen (Fig.…”
Section: Resultssupporting
confidence: 89%
“…The spleen of adult mice contains a pool of multipotent CD45 − /Hox11 + stem cells that reside in the sub-capsular red pulp and are capable of differentiating into diverse lineages4647. Consistent with these reports, we observed a limited number of cells with nuclear Sox2 protein expression in the sub-capsular region of WT mouse spleen (Fig.…”
Section: Resultssupporting
confidence: 89%
“…We concluded that CFA was insufficient to decrease the inflammatory cell infiltrates in SGs and started to investigate for additional approaches to our proposed combined therapy. Recent evidence from our collaborators (DL Faustman and S Kodama) indicated that multipotent stem cells of non-lymphoid lineage (CD45-negative; CD45 − ) from the spleen contributed to the regeneration of bone, inner ear, cranial nerves, islets, hearts, and of particular interest to our work, salivary glands [12], [13], [14], [15]. The spleen and bone marrow are closely related organs, and both are among the first sites of hematopoiesis during gestation.…”
Section: Introductionmentioning
confidence: 82%
“…5,6 However, these drugs cannot promote tear secretion from the lacrimal gland, so the application of lacrimal glandregenerative techniques, such as stem cell transplantation or induction of induced pluripotent stem cells, may be essential to increase tear volume. [7][8][9] Currently, these techniques have not been clinically approved for use.…”
mentioning
confidence: 99%